Enter assignee name

Forward Citations = 17

Loading Chart...

6 inventors (with patents filed for the assignee):

Karl-Hermann Schlingensiepen (4 out of 14 patents)

Reimar Schlingensiepen (4 out of 8 patents)

Wolfgang Brysch (3 out of 7 patents)

4. Georg-Ferdinand Schlingensiepen (1 out of 3 patents)

5. Ulrich Bogdahn (1 out of 5 patents)

6. Georg-F Schlingensiepen (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8703729 - Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene (2014-04-22),

2. 8629117 - Method for stimulating the immune system (2014-01-14),

3. 7667027 - Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) (2010-02-23),

4. 7326783 - Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms (2008-02-05),

Biognostik Gesellschaft Für Biomolekulare Diagnostik MbH is a leading biotechnology company that specializes in biomolecular diagnostics. With a team of expert scientists and cutting-edge technology, Biognostik offers innovative diagnostic solutions for a variety of diseases and conditions. Their mission is to improve healthcare outcomes through advanced molecular testing.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#6 in Gottingen

#6,929 in Germany

Gottingen, Germany

Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh